James E. Flynn 13D and 13G filings for Aerie Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-10 10:00 am Sale | 2022-12-31 | 13G | Aerie Pharmaceuticals, Inc. AERI | James E. Flynn | 0 0.000% | -4,695,020 (Position Closed) | Filing |
| 2022-02-11 4:08 pm Purchase | 2021-12-31 | 13G | Aerie Pharmaceuticals, Inc. AERI | James E. Flynn | 4,695,020 9.910% | 2,159,519 (+85.17%) | Filing |
| 2021-08-16 5:06 pm Purchase | 2021-08-04 | 13G | Aerie Pharmaceuticals, Inc. AERI | James E. Flynn | 2,535,501 5.370% | 2,041,285 (+413.03%) | Filing |
| 2020-06-30 4:35 pm Sale | 2020-06-30 | 13G | Aerie Pharmaceuticals, Inc. AERI | James E. Flynn | 494,216 1.060% | -2,037,931 (-80.48%) | Filing |
| 2020-03-24 4:35 pm Purchase | 2020-03-13 | 13G | Aerie Pharmaceuticals, Inc. AERI | James E. Flynn | 2,532,147 5.450% | 759,892 (+42.88%) | Filing |
| 2020-02-13 12:31 pm Sale | 2019-12-31 | 13G | Aerie Pharmaceuticals, Inc. AERI | James E. Flynn | 1,772,255 3.830% | -1,160,732 (-39.58%) | Filing |